-transparent.png){kind=logo}
A glycosaminoglycan with scleroderma-inducing effect was isolated and partially purified from the urine of patients with systemic scleroderma. The glycosaminoglycan was an N-sulfated glycosaminoglycuronan and its high total sulfate and 2,5-anhydromannose contents suggest that the glycosaminoglycan is a degradation product of heparin or polysulfated heparin sulfate. Furthermore, the composition of the above glycosaminoglycan was similar to that of the N-sulfated glycosaminoglycan which we observed previously in uninvolved skin of scleroderma.
Related Publications
H Ishikawa, and
Y Saito, and
A Yamakage, and
M Kitabatake
January 1985,
Dermatologica,
H Ishikawa, and
Y Saito, and
A Yamakage, and
M Kitabatake
January 1988,
Acta dermato-venereologica,
H Ishikawa, and
Y Saito, and
A Yamakage, and
M Kitabatake
January 1979,
Dermatologica,
H Ishikawa, and
Y Saito, and
A Yamakage, and
M Kitabatake
February 1982,
Dermatologica,
H Ishikawa, and
Y Saito, and
A Yamakage, and
M Kitabatake
January 1974,
International urology and nephrology,
H Ishikawa, and
Y Saito, and
A Yamakage, and
M Kitabatake
May 1983,
The Journal of laboratory and clinical medicine,
H Ishikawa, and
Y Saito, and
A Yamakage, and
M Kitabatake
January 1976,
Vestnik rentgenologii i radiologii,
H Ishikawa, and
Y Saito, and
A Yamakage, and
M Kitabatake
May 1987,
Vrachebnoe delo,
H Ishikawa, and
Y Saito, and
A Yamakage, and
M Kitabatake
January 1989,
JPEN. Journal of parenteral and enteral nutrition,
H Ishikawa, and
Y Saito, and
A Yamakage, and
M Kitabatake
November 2012,
Clinical rheumatology,
